Snorting the Clivus Away: an Extreme Case of Cocaine-induced Midline Destructive Lesion
Overview
Affiliations
Cocaine is a drug with relevant socioeconomic and clinical implications, which is usually recreationally used for its stimulant effects. It is widely known that the habit of snorting cocaine is associated with a peculiar type of drug-induced chronic rhinitis, which leads to inflammation of the sinonasal mucosa, slowly progressing to a destruction of nasal, palatal and pharyngeal tissues. These characteristic lesions due to cocaine abuse are commonly called cocaine-induced midline destructive lesions (CIMDL). Diagnosis is not always straightforward, since various conditions, mainly vasculitis, might mimic this acquired condition. The extent of pharyngeal involvement varies, although often a prolonged abuse can trigger a progressive destruction of oral and nasal tissues, with development of infections and recurrent inflammation. Our article focuses on cocaine as a world health problem with important ear, nose and throat implications and discusses the difficulties in diagnosing and treating CIMDL, through a case report.
Almansouri A, Tham A, Abobotain A, Almarwani M, Tewfik M, Sirhan D Neurosurg Pract. 2025; 5(1):e00076.
PMID: 39957861 PMC: 11783658. DOI: 10.1227/neuprac.0000000000000076.
Cocaine-induced destruction of the palate: a diagnostic and management challenge.
Maloney B, Hinchion K, Conlon N, Omer O, Pierse D Br Dent J. 2024; 237(6):465-471.
PMID: 39333814 PMC: 11436349. DOI: 10.1038/s41415-024-7834-5.
Cocaine- and Levamisole-Induced Vasculitis: Defining the Spectrum of Autoimmune Manifestations.
Iorio L, Davanzo F, Cazzador D, Codirenzi M, Fiorin E, Zanatta E J Clin Med. 2024; 13(17).
PMID: 39274328 PMC: 11396482. DOI: 10.3390/jcm13175116.
Oral Rehabilitation for a Patient with Cocaine-Induced Midline Destructive Lesions.
Berberi A, Azar E Case Rep Otolaryngol. 2024; 2024:7109261.
PMID: 38939732 PMC: 11208820. DOI: 10.1155/2024/7109261.
Mucocutaneous Manifestations of Recreational Drug Use.
Alexander-Savino C, Mirowski G, Culton D Am J Clin Dermatol. 2024; 25(2):281-297.
PMID: 38217568 DOI: 10.1007/s40257-023-00835-y.